The fatty acid profile of blood plasma in men from rural areas of Novosibirsk region with arterial hypertension
V. S. Shramko,
E. M. Stakhneva,
L. V. Shcherbakova,
E. V. Kashtanova,
A. D. Afanasyeva,
E. V. Garbuzova,
Yu. I. Ragino https://doi.org/10.52727/2078-256X-2026-22-1-73-83
Abstract
Different fatty acids (FA) have different effects on oxidative stress, insulin resistance, inflammation, and endothelial dysfunction, which may eventually contribute to the development of hypertension. Aim – to study the levels of unsaturated FA (UFA) in blood plasma in men aged 35-74 years from rural areas of the Novosibirsk region in the presence of hypertension, as well as to analyze the association of UFA with the presence of hypertension.
Material and methods. Rural residents aged 35-74 were examined as part of a single-center observational single-stage epidemiological study in the Novosibirsk region. The study included 300 men with an average age of 60.4 ± 10.6 years. The levels of UFA in blood plasma were determined by gas chromatography with mass-selective detection: omega-3 (alpha-linolenic, eicosapentaenoic, docosahexaenoic); omega-6 (linoleic, gamma-linolenic, digomo-gamma-linolenic, arachidonic, docosatetraenoic, docosapentaenoic); omega-9 (hexadecenoic, oleic acid, mead, selacholic).
Results. A comparative analysis of the studied indicators using the Kruskal-Wallace test revealed statistically significant differences in the content of linoleic acid (p = 0.043) between the subgroups with hypertension of 1, 2 and 3 degrees. These differences are mainly due to the group of patients with grade 3 hypertension. A detailed study revealed a statistically significant increase in gamma-linolenic acid levels by 16 % and 21 % in the subgroups with grade 2 hypertension (p = 0.046) and grade 3 hypertension (p = 0.014), respectively, compared with the control group. A correlation analysis revealed a direct relationship between gamma-linolenic acid and hypertension (r = 0.152; p = 0.008).
Conclusions. The present study found a direct relationship between the level of omega-6 gamma-linolenic acid and the severity of hypertension in men aged 35–74 years from rural areas of Novosibirsk region.
Supporting agencies: The work was carried out within the framework of the budget theme under the State Assignment No. FWNR-2024-0004 and with the support of a grant from the Government of the Novosibirsk Region No. 10-2025-034764.
About the Authors
V. S. Shramko
Research Institute of Internal and Preventive Medicine – Branch of the Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences
Russian Federation
Russian Federation
Viktoriya S. Shramko, candidate of medical sciences, researcher at the laboratory of clinical biochemical and hormonal studies of therapeutic diseases, head of the department of clinical-biochemical and molecular genetic research methods
175/1, Boris Bogatkov st., Novosibirsk, 630089
E. M. Stakhneva
Research Institute of Internal and Preventive Medicine – Branch of the Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences
Russian Federation
Russian Federation
Ekaterina M. Stakhneva, candidate of biological sciences, senior researcher at the laboratory of clinical biochemical and hormonal studies of therapeutic diseases, head of the department of clinical-biochemical and molecular genetic research methods
175/1, Boris Bogatkov st., Novosibirsk, 630089
L. V. Shcherbakova
Research Institute of Internal and Preventive Medicine – Branch of the Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences
Russian Federation
Russian Federation
Lilia V. Shcherbakova, senior researcher at the laboratory of clinical, population and preventive research of therapeutic and endocrine diseases, head of the department of extra-budgetary works
175/1, Boris Bogatkov st., Novosibirsk, 630089
E. V. Kashtanova
Research Institute of Internal and Preventive Medicine – Branch of the Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences
Russian Federation
Russian Federation
Elena V. Kashtanova, doctor of biological sciences, senior researcher at the laboratory of clinical biochemical and hormonal studies of therapeutic diseases, head of the department of clinical-biochemical and molecular genetic research methods
175/1, Boris Bogatkov st., Novosibirsk, 630089
A. D. Afanasyeva
Research Institute of Internal and Preventive Medicine – Branch of the Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences
Russian Federation
Russian Federation
Alena D. Afanasyeva, candidate of medical sciences, head of the laboratory of genetic and environmental determinants of the human life cycle
175/1, Boris Bogatkov st., Novosibirsk, 630089
E. V. Garbuzova
Research Institute of Internal and Preventive Medicine – Branch of the Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences
Russian Federation
Russian Federation
Evgenia V. Garbuzova, candidate of medical sciences, senior researcher at the laboratory of genetic and environmental determinants of the human life cycle
175/1, Boris Bogatkov st., Novosibirsk, 630089
Yu. I. Ragino
Research Institute of Internal and Preventive Medicine – Branch of the Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences
Russian Federation
Russian Federation
Yulia I. Ragino, doctor of medical sciences, professor, corresponding member of the russian academy of sciences, head; chief researcher at the laboratory of clinical biochemical and hormonal studies of therapeutic diseases
175/1, Boris Bogatkov st., Novosibirsk, 630089
References
1. GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388 (10053): 1659–1724. doi: 10.1016/S0140-6736(16)31679-8
2. Oparil S., Acelajado M.C., Bakris G.L., Berlowitz D.R., Cífková R., Dominiczak A.F., et al. Hypertension. Nat. Rev. Dis. Primers. 2018; 4: 18014. doi: 10.1038/nrdp.2018.14
3. Muromtseva G.A., Kontsevaya A.V., Konstantinov V.V., Artamonova G.V., Gatagonova T.M., Duplyakov D.V. et al. The prevalence of non-infectious diseases risk factors in Russian population in 2012–2013 years. the results of ECVD-RF. Cardiovasc. Ther. Prev. 2014; 13 (6): 4–11. (In Russ). doi: 10.15829/1728-8800-2014-6-4-11
4. Williams B., Mancia G., Spiering W., Agabiti Rosei E., Azizi M., Burnier M. et al. ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur. Heart. J. 2018; 39 (33): 3021–3104. doi: 10.1093/eurheartj/ehy339
5. Arghavani H., Bilodeau J.F., Rudkowska I. Association Between Circulating Fatty Acids and Blood Pressure: A Review. Curr. Nutr. Rep. 2025; 14 (1): 15. doi: 10.1007/s13668-024-00602-3
6. Vlasov A.A., Salikova S.P., Grinevich V.B., Bystrova O.V., Osipov G.A., Zaplatina A.A. Dynamics of polyunsaturated fatty acids in the blood of patients with chronic heart failure. Russ. J. Cardiol. 2018; (1): 27–31. (In Russ). doi: 10.15829/1560-4071-2018-1-27-31
7. Abdelhamid A.S., Brown T.J., Brainard J.S., Biswas P., Thorpe G.C., Moore H.J. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst. Rev. 2020; 3 (3): CD003177. doi: 10.1002/14651858.CD003177
8. Hooper L., Al-Khudairy L., Abdelhamid A.S., Rees K., Brainard J.S., Brown T.J., et al. Omega-6 fats for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst. Rev. 2018; 11 (11): CD011094. doi: 10.1002/14651858.CD011094.pub4
9. Kobalava Z.D., Konradi A.O., Nedogoda S.V., Shlyakhto E.V., Arutyunov G.P., Baranova E.I. et al. Arterial hypertension in adults. Clinical guidelines 2020. Russ. J. Cardiol. 2020; 25 (3): 3786. (In Russ). doi: 10.15829/1560-4071-2020-3-3786
10. Korneeva N.V., Gavrilov E.S. Hypertension: smoking or quit. Clinical difficulties. Cardiovasc. Ther. Prev. 2023; 22 (10): 3692. (In Russ)]. doi: 10.15829/1728-8800-2023-3692
11. Das U.N. Bioactive Lipids in Age-Related Disorders. Adv. Exp. Med. Biol. 2020; 1260: 33–83. doi: 10.1007/978-3-030-42667-5_3
12. ГGovorin A.V., Lareva N.V., Hyshiktuyev B.S., Filev A.P. Changes in plasma lipid composition in patients with essential hypertension. Russ. J. Cardiol. 2003; (3): 19–24. (In Russ).
13. Sergeant S., Rahbar E., Chilton F.H. Gamma-linolenic acid, dihommo-gamma linolenic, eicosanoids and inflammatory processes. Eur. J. Pharmacol. 2016; 785: 77–86. doi: 10.1016/j.ejphar.2016.04.020
14. Kaikkonen J.E., Jula A., Viikari J.S.A., Juonala M., HutriKähönen N., Kähönen M., et al. Associations of Serum Fatty Acid Proportions with Obesity, Insulin Resistance, Blood Pressure, and Fatty Liver: The Cardiovascular Risk in Young Finns Study. J Nutr. 2021; 151 (4): 970–978. doi: 10.1093/jn/nxaa409
15. Aristizabal J.C., González-Zapata L.I., Estrada-Restrepo A., Monsalve-Alvarez J., Restrepo-Mesa S.L., Gaitán D. Concentrations of Plasma Free Palmitoleic and Dihomo-Gamma Linoleic Fatty Acids Are Higher in Children with Abdominal Obesity. Nutrients. 2018; 10 (1): 31. doi: 10.3390/nu10010031
16. Yang B., Ding F., Yan J., Ye X.W., Xu X.L., Wang F.L., et al. Exploratory serum fatty acid patterns associated with blood pressure in community-dwelling middle-aged and elderly Chinese. Lipids Health Dis. 2016; 15: 58. doi: 10.1186/s12944-016-0226-3
17. Kharazmi-Khorassani J., Ghafarian Zirak R., Ghazizadeh H., Zare-Feyzabadi R., Kharazmi-Khorassani S., Naji-ReihaniGarmroudi S., et al. The role of serum monounsaturated fatty acids (MUFAs) and polyunsaturated fatty acids (PUFAs) in cardiovascular disease risk. Acta Biomed. 2021; 92 (2): e2021049. doi: 10.23750/abm.v92i2.9235
18. Shramko V.S., Simonova G.I., Khudyakova A.D., Muromtseva G.A., Imaeva A.E., Balanova Yu.A., et al. The content of fatty acids in blood plasma in men with arterial hypertension («ESSERF3» in the Novosibirsk region). Arterial’naya gipertenziya = Arter. Hypertension. 2024; 30 (1): 46–57 (In Russ)]. doi:10.18705/1607-419X-2024-2364
19. Bermúdez M.A., Pereira L., Fraile C., Valerio L., Balboa M.A., Balsinde J. Roles of Palmitoleic Acid and Its Positional Isomers, Hypogeic and Sapienic Acids, in Inflammation, Metabolic Diseases and Cancer. Cells. 2022; 11 (14): 2146. doi: 10.3390/cells11142146
20. Kawashima H., Yoshizawa K. The physiological and pathological properties of Mead acid, an endogenous multifunctional n-9 polyunsaturated fatty acid. Lipids Health Dis. 2023; 22 (1): 172. doi: 10.1186/s12944-023-01937-6
Review
For citations:
Shramko V.S., Stakhneva E.M., Shcherbakova L.V., Kashtanova E.V., Afanasyeva A.D., Garbuzova E.V., Ragino Yu.I. The fatty acid profile of blood plasma in men from rural areas of Novosibirsk region with arterial hypertension. Ateroscleroz. 2026;22(1):73-83. (In Russ.) https://doi.org/10.52727/2078-256X-2026-22-1-73-83
Views:
143
JATS XML
Email this article 
